Human papillomavirus vaccine recombinant bivalent - EyeGeneAlternative Names: EG-HPV; HPV VLP vaccine - Eyegene; Human papillomavirus (types 16 and 18) L1 virus-like particle vaccine - EyeGene
Latest Information Update: 31 Mar 2016
At a glance
- Originator EyeGene
- Class Cancer vaccines; Papillomavirus vaccines; Virus-like particle vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Cervical cancer; Human papillomavirus infections; Penile cancer
Most Recent Events
- 01 Jan 2013 Phase-I clinical trials in Human papillomavirus infections in South Korea (Parenteral)